CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Overview Fund Activity
Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

52 hedge funds and large institutions have $83.8M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
21
Reduced
9
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17M
2
EWM
2
Evercore Wealth Management
New York
$553K
3
BlackRock
3
BlackRock
New York
$2.51M
4
Millennium Management
4
Millennium Management
New York
$585K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$852K

Top Sellers

1
ACP
1
Acuta Capital Partners
California
$0
2
ABG
2
Ally Bridge Group
New York
$0
3
SI
3
Sofinnova Investments
California
$0
4
CCM
4
CAAS Capital Management
New York
$396K
5
SFM
5
Sphera Funds Management
Israel
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ACP
51
Acuta Capital Partners
California
– -$4.46M -391,974 Closed
ABG
52
Ally Bridge Group
New York
– -$3.63M -319,538 Closed
SI
53
Sofinnova Investments
California
– -$2.04M -179,450 Closed
SFM
54
Sphera Funds Management
Israel
– -$1.12M -98,860 Closed
GTCM
55
Gyon Technologies Capital Management
New Jersey
– -$254K -22,345 Closed
Jane Street
56
Jane Street
New York
– -$180K -15,843 Closed
E
57
Ergoteles
New York
– -$152K -13,355 Closed
HNWAG
58
High Net Worth Advisory Group
Florida
– -$6K -500 Closed
SOW
59
State of Wyoming
Wyoming
– -$1K -44 Closed
1 2
3